Press release
Walter Land: Crucial role of innate immune events in organ transplantation
"There is growing evidence that innate immune events provide critical initiating steps in immune responses to transplantation and key pathogenic steps in the tissue damage characteristic of humoral and cellular rejection. In fact, when I coined the term Innate Alloimmunity in 2002, I never foresaw the effect it would have on transplant thinking today," Professor Dr. Walter Land (Munich) emphasizes in his textbook "Innate Alloimmunity"."This book reflects the beginning of an era. In the field of organ transplantation, research regarding innate immunity has just begun. The complex but orchestrated pathways leading from an initial allograft injury to final allograft rejection are not yet fully understood. However, evidence is accumulating, suggesting a crucial role of innate immune events in organ transplantation," Land notes.
Dr. J. S. Bromberg (Baltimore) comments (American Journal of Transplantation 12/2012): "Land has captured what is a major intellectual force shaping both general immunology and transplantation. ´Innate Alloimmunity´ may have been considered an oxymoron a number of years ago, but with the realization that the innate immune system covers huge swaths of the response to tissue injury, tissue repair and adaptive immunity, it is now apparent that the innate immune response is not only as important as adaptive responses in transplantation, but that innate immunity is perhaps the locus where therapeutic efforts should now be concentrated."
Dr. A. Siedlecki (Boston) comments (Transplantation 10/2012): This book "is an essential resource for every transplant physician or researcher providing them a roadmap for transplantation science into the next decade."
Walter Gottlieb Land: Innate Alloimmunity. Part 1: Innate Immunity and Host Defense. Baskent University/Pabst Science Publishers 2011, 618 pages hardcover, 978-3-89967-737-9
Walter Gottlieb Land: Innate Alloimmunity. Part 2: Innate Immunity and Allograft Rejection. Baskent University/Pabst Science Publishers 2011, 732 pages hardcover, ISBN 978-3-89967-738-6
Pabst Science Publishers (Lengerich/Westfalia, Germany) is publishing ten psychological and nine medical journals; furthermore, Pabst is publishing more than hundred psychological and medical books per year – partly specialized scientific literature, partly specialist literature written for laypeople.
Pabst Science Publishers
Eichengrund 28
49525 Lengerich
Tel. 05484-308
Fax 05484-550
E-Mail: pabst.publishers@t-online.de
Internet: www.pabst-science-publishers.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Walter Land: Crucial role of innate immune events in organ transplantation here
News-ID: 228635 • Views: …
More Releases from Pabst Science Publishers

Health literacy: How to improve health behaviors
Health literacy is defined as "people´s knowledge, motivation and competences to access, understand, appraise and apply information to make judgements and take decisions in everyday life healthcare concerning disease prevention and health promotion to maintain and improve quality of life during the life course." In a new volume Anne-Kathrin Mayer and colleagues shed light on the concept of health literacy from different disciplines: psychology, educational sciences, health sciences and…

Health literacy: how to improve the advantages and to reduce the risks
The new volume "Health literacy across the lifespan" stresses the importance of health literacy for changing multiple health-risk-factors. Anne-Kathrin Mayer and colleagues shed light on a concept from different disciplines: psychology, educational sciences, health sciences and public health, communication sciences, and information sciences.
It is undisputed that health is strongly influenced by individual efforts aimed at the promotion of health and the prevention of illness or recovery from diseases. These…

Directed deceased donation: beyond the impartial allocation system
"Within a pluralistic account of morality, partial values have a merit of their own and should be assessed in their own terms. These values are extremely relevant in the field of organ transplantation, but are misunderstood at a political level where partiality is put at par with injustice, and where fairness is exclusively taken as impartial justice." Dr. Medard Hilhorst (Erasmus Medical University Rotterdam) argues "that partial values are fundamental…

Transplantation: Prisoners are killed for their organs in China
Transplantation: China is the only country in the world systematically using organs from prisoners for transplantation, Professor Huige Li reports. For over 40 years, executed prisoners were used as the main organ source in China. It´s a profitable international business. A number of Chinese Hospitals claimed that they could provide liver transplants in the time range between 3 to 30 days.
The report appeared in "Ethical, Legal and Psychosocial Aspects…
More Releases for Innate
Sound Therapy Market Is Booming So Rapidly By 2032 | Innate Sounds, Sound Oasis, …
The Sound Therapy Market Research Report is the result of extensive research and analysis conducted by our team of experienced market researchers. It encompasses a wide range of critical factors influencing the Sound Therapy Market Growth from 2025 to 2032, including competitive landscape, consumer behavior, and technological advancements. This report serves as a valuable resource for industry players, helping them make informed decisions and stay ahead of the competition in…
Oropharyngeal Cancer Market Future Business Opportunities 2025-2032 |Innate Phar …
Latest Report, titled "Oropharyngeal Cancer Market" Trends, Share, Size, Growth, Opportunity and Forecast 2025-2032, by CoherentMI offers a comprehensive analysis of the industry, which comprises insights on the market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The oropharyngeal cancer market is estimated to be valued at USD 2.11 Bn in 2024 and is expected to reach USD 3.05 Bn by 2031, growing at…
Innate Pharma's Lacutamab market size expected to increase many folds by 2032, r …
DelveInsight has recently published a report on "Lacutamab Market Forecast Report" providing an in-depth analysis of the Lacutamab market analysis and forecasts up to 2032 in the seven major markets (7MM) (i.e. the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The comprehensive report provides an analysis of Lacutamab market potential and market share analysis in the Cutaneous T-cell lymphoma therapeutics space across the 7MM…
Porcine Innate Immunity Market 2021 Clinical Analysis and Precise Outlook-NCBI, …
The “Porcine Innate Immunity Market” report is an in-depth study of the market, along with an analysis of its key segments. The relationship is built through extensive primary and secondary research. In-depth market data is generated through interviews and data collection from industry experts and professionals. The study is a detailed document on key aspects of the markets including trends, segmentation, growth prospects, opportunities, challenges, and competitive analysis.
The innate immune…
Lawsuit filed for Investors in shares of Innate Pharma S.A. (NASDAQ: IPHA)
An investor, who purchased shares of Innate Pharma S.A. (NASDAQ: IPHA), filed a lawsuit over alleged violations of Federal Securities Laws by Innate Pharma S.A..
Investors who purchased shares of Innate Pharma S.A. (NASDAQ: IPHA) have certain options and for certain investors are short and strict deadlines running. Deadline: December 22, 2020. NASDAQ: IPHA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
France based Innate Pharma…
Investigation announced for Investors in shares of Innate Pharma S.A. (NASDAQ: I …
Innate Pharma S.A. is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Innate Pharma S.A. (NASDAQ: IPHA), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether certain statements by Innate Pharma S.A. regarding its business, its prospects and its operations were materially false and misleading…